These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3076787)

  • 1. Serum lipid changes in patients with mild to moderate essential hypertension taking nicardipine and propranolol.
    Naukkarinen VA
    Br J Clin Pract; 1988 Dec; 42(12):509-13. PubMed ID: 3076787
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicardipine or propranolol combined with hydrochlorothiazide in patients with essential hypertension.
    Arriaga-Gracia J; Sánchez-Garcia JL; González-García CA
    Proc West Pharmacol Soc; 1993; 36():39-43. PubMed ID: 8378396
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effects of nicardipine hydrochloride and hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind parallel study.
    Creytens G; Saelen A
    Br J Clin Pract; 1986 Dec; 40(12):518-23. PubMed ID: 3307862
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
    Naukkarinen VA; Karppinen K; Sarna S
    Eur J Clin Pharmacol; 1987; 33(2):119-26. PubMed ID: 3319640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative studies on the effects of propranolol and acebutolol on blood pressure, serum lipids and lipoproteins in patients with primary hypertension].
    Sznajderman M; Bednarska-Makaruk M; Niegowska J; Makowiecka-Cieśla M
    Pol Tyg Lek; 1991 Aug 5-19; 46(32-34):601-4. PubMed ID: 1669122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and acceptability of nicardipine and propranolol, alone and in combination, in mild to moderate hypertension.
    Maclean D; Mitchell ET; Laing EM; Macdonald FC; Gough KJ; Dow RJ; McDevitt DG
    Br J Clin Pharmacol; 1989 May; 27(5):569-80. PubMed ID: 2667597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised double blind cross over trial of atenolol and propranolol in mild to moderate hypertension.
    Mahajan V; Puri R; Gattani RK; Chatterji T
    J Assoc Physicians India; 1987 Jun; 35(6):431-2. PubMed ID: 3308837
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicardipine in the treatment of essential hypertension controlled 6-month-study comparing nicardipine with propranolol at rest and during exercise.
    Danielsson A; Bjerle P; Ek B; Steen L; Suhr O
    Eur J Clin Pharmacol; 1987; 33(1):15-20. PubMed ID: 3319637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW; Bader PI; Creason PL; Townsend DW; Conn PS; Lakes MK; Campbell NM
    J Indiana State Med Assoc; 1981 Jul; 74(7):444-9. PubMed ID: 7024422
    [No Abstract]   [Full Text] [Related]  

  • 12. A cross-over trial comparing the effects of acebutolol and propranolol on the serum lipids and hypertension.
    Ghosh DC; Dutta S; Sarkar N
    Indian Heart J; 1989; 41(5):292-5. PubMed ID: 2599537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of propranolol on the lipid pattern and post-prandial lipemia in patients with essential arterial hypertension].
    Ambrosio GB; Donadon W; Pagnan A; Zamboni S; Dal Palù C
    Clin Ter; 1979 Dec; 91(6):565-73. PubMed ID: 544160
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.
    Nievel JG; Havard CW; Douglas-Jones AP
    Eur J Clin Pharmacol; 1987; 33(1):21-5. PubMed ID: 3691592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A 10-year follow-up of men with mild hypertension. Bendroflumethiazide and propranolol give equal effect in treatment of high blood pressure].
    Andersson OK; Widgren B; Berglund G
    Lakartidningen; 1985 Mar; 82(13):1159-62. PubMed ID: 3887074
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
    Benvenuti C; Guerini Rocco C; Trezzi P
    Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of nicardipine hydrochloride and propranolol in the treatment of hypertension.
    Morgan TO; Anderson A; Wilson D
    J Int Med Res; 1987; 15(4):189-97. PubMed ID: 3653498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicardipine versus propranolol in essential tumor.
    Jiménez-Jiménez FJ; Garcia-Ruiz PJ; Cabrera-Valdivia F
    Acta Neurol (Napoli); 1994 Aug; 16(4):184-8. PubMed ID: 7856472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.